Quick Overview: Experts discuss the importance of multidisciplinary assessment of Lisa Ni, MD Resident PGY3, UCSF Department of Radiation Oncology Presentation Title: Volumetric Response of Benjamin P. Levy, MD; Suresh S. Ramalingam, MD; Hossein Borghaei, DO, MS; Naiyer A. Rizvi, MD; Thomas E. Stinchcombe, MD ...

Treating Egfr Nsclc Brain Metastases - Detailed Overview & Context

Experts discuss the importance of multidisciplinary assessment of Lisa Ni, MD Resident PGY3, UCSF Department of Radiation Oncology Presentation Title: Volumetric Response of Benjamin P. Levy, MD; Suresh S. Ramalingam, MD; Hossein Borghaei, DO, MS; Naiyer A. Rizvi, MD; Thomas E. Stinchcombe, MD ... Benjamin P. Levy, MD; Zofia Piotrowska, MD; Lyudmila A. Bazhenova, MD; and Jonathan W. Riess, MD, MS, consider the ... Targeted Therapies Forum 2022: In this video Drs. Isabel Preeshagul and Narjust Florez, discuss Lizza Hendriks, MD, PhD, Maastricht University, Maastricht, Netherlands, talks on

Panelists Suresh S. Ramalingam, MD, and Giorgio Scagliotti, MD, PhD, describe the prevalence of CNS Kathryn Beal, MD, Sandip Patel, MD, and Manmeet Ahluwalia, MD, FACP, discuss management of CNS Laurie Gaspar, MD, professor and chair of the Department of Radiation Oncology, Grohne Chair in Clinical Oncology, University of ... Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill An informative discussion with Duke Center Spine and John Conibear, MBBCh, BSc, MSc, MRCP, FRCR, Nottingham City Hospital, Nottingham, UK, discusses the impact of

Benjamin P. Levy, MD; Paul K. Paik, MD; and Anne S. Tsao, MD, discuss the rationale for Suresh S. Ramalingam, MD, professor of hematology and medical oncology at the Emory University School of Medicine, ... Manmeet Ahluwalia, MD, Cleveland Clinic, discusses treatments that are showing promise for patients with

Photo Gallery

Treating EGFR+ NSCLC Brain Metastases
Volumetric Response of Brain Metastases in EGFR mutant NSCLC | Lisa Ni, MD
Treatment of EGFR+ NSCLC Brain Metastases
Osimertinib in EGFR-Positive NSCLC With Brain Metastases
How do you approach brain metastases in EGFR-mutated lung cancer?
EGFR Mutated NSCLC with Brain Metastasis - 2022 Program: Targeted Therapies Forum
EGFR Lung Cancer Treatment Explained: From Diagnosis to Advanced Disease
Treatment options for brain metastases in NSCLC
Managing CNS Metastases in EGFR-Positive NSCLC
EGFR-Mutated Lung Cancer: Co-Mutations and Radiation for Brain Metastases - 2024 Lung Cancer OncTalk
Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases
Dr. Gaspar on Treating Brain Metastases in Lung Cancer
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored